Clincosm LogoSign in Get a demo

rheumatoid arthritis (ra)

Showing 1 - 25 of 42
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Rheumatoid Arthritis (RA), Inflammatory Bowel Disease - IBD1 Trial in Guizhou (ZL-82 12.5mg, ZL-82 25mg, ZL-82 50mg)

Recruiting
  • Rheumatoid Arthritis (RA)
  • Inflammatory Bowel Disease - IBD1
  • ZL-82 12.5mg
  • +7 more
  • Guizhou, GuiYang, China
    Affiliated Hospital of Guizhou Medical University
Sep 19, 2023

Assess Frequency Of Serious Infections In Clinical Practice In

Recruiting
  • Rheumatoid Arthritis (RA)
    • Gamagori, Aichi, Japan
    • +893 more
    Jan 24, 2023

    Oral Upadacitinib Tablets to Assess Treatment Patterns,

    Active, not recruiting
    • Rheumatoid Arthritis (RA)
      • La Plata, Buenos Aires, Argentina
      • +262 more
      Jan 25, 2023

      Oral Upadacitinib Tablets to Assess Change in Disease Symptoms

      Recruiting
      • Rheumatoid Arthritis (RA)
        • Edmonton, Alberta, Canada
        • +38 more
        Jan 17, 2023

        Rheumatoid Arthritis (RA) Trial in China, Korea, Republic of, Taiwan (Peficitinib, Plaebo, Disease-modifying antirheumatic drugs

        Completed
        • Rheumatoid Arthritis (RA)
        • Anhui, China
        • +42 more
        Jan 7, 2023

        Oral Upadacitinib Tablets to Assess Adverse Events and Change in

        Recruiting
        • Rheumatoid Arthritis (RA)
        • +3 more
          • Bucheon, Gyeonggido, Korea, Republic of
          • +3 more
          Nov 8, 2022

          Rheumatoid Arthritis (RA) Trial in Los Angeles (Acthar)

          Recruiting
          • Rheumatoid Arthritis (RA)
          • Los Angeles, California
            UCLA David Geffen School of Medicine, Division of Rheumatology
          Nov 4, 2022

          Rheumatoid Arthritis (RA) Trial in Sohag (PCR polymorphism)

          Recruiting
          • Rheumatoid Arthritis (RA)
          • PCR polymorphism
          • Sohag, Egypt
            Sohag university hospital
          Oct 19, 2022

          Degenerative Hip Joint Disease, Rheumatoid Arthritis (RA), Femoral Neck Fractures Trial in China (OR3O™ - Dual Mobility System,

          Recruiting
          • Degenerative Hip Joint Disease
          • +6 more
          • OR3O™ - Dual Mobility System
          • Conventional
          • Shijiazhuang, Hebei, China
          • +3 more
          Aug 30, 2022

          it's Association With Disease Activity in Egyptian Rheumatoid

          Not yet recruiting
          • Rheumatoid Arthritis (RA)
          • Vit D
          • (no location specified)
          Aug 1, 2022

          Adalimumab on Health Outcomes in Chinese Immune-Mediated

          Completed
          • Ankylosing Spondylitis (AS)
          • +2 more
            • Shenzhen, Guangdong, China
            • +9 more
            Jul 6, 2022

            Rheumatoid Arthritis (RA) Trial in Suzhou (SHR0302?[14C]SHR0302)

            Completed
            • Rheumatoid Arthritis (RA)
            • Suzhou, Jiangsu, China
              the first affiliated hospital of Soochow University
            Jun 30, 2022

            Safety of Abatacept Treatment in Denmark Using Danish Database

            Active, not recruiting
            • Rheumatoid Arthritis (RA)
            • Psoriatic Arthritis (PsA)
              • Princeton, New Jersey
                Local Institution
              Jun 13, 2022

              Rheumatoid Arthritis (RA) Trial in Worldwide (ABBV-154, Placebo)

              Active, not recruiting
              • Rheumatoid Arthritis (RA)
              • Phoenix, Arizona
              • +222 more
              Jun 7, 2022

              Real World Effectiveness of Upadacitinib as Monotherapy or in

              Completed
              • Rheumatoid Arthritis (RA)
                • Ulm, Baden-Wuerttemberg, Germany
                • +51 more
                Mar 10, 2022

                Rheumatoid Arthritis (RA) Trial in Brazil, China, Korea, Republic of (Upadacitinib, Placebo)

                Completed
                Has Results
                • Rheumatoid Arthritis (RA)
                • Curitiba, Parana, Brazil
                • +42 more
                Aug 30, 2021

                Rheumatoid Arthritis (RA) Trial in Worldwide (Elsubrutinib, Upadacitinib, Placebo for elsubrutinib)

                Terminated
                Has Results
                • Rheumatoid Arthritis (RA)
                • Woluwe-Saint-Lambert, Bruxelles-Capitale, Belgium
                • +29 more
                Aug 18, 2021

                Rheumatoid Arthritis (RA) Trial in Korea, Republic of (tacrolimus, methotrexate, adalimumab)

                Completed
                • Rheumatoid Arthritis (RA)
                • Daegu, Korea, Republic of
                • +9 more
                Aug 26, 2021

                Rheumatoid Arthritis (RA) Trial in Worldwide (ABBV-3373, Placebo for ABBV-3373, Adalimumab)

                Completed
                Has Results
                • Rheumatoid Arthritis (RA)
                • Huntsville, Alabama
                • +29 more
                Jun 29, 2021

                Rheumatoid Arthritis (RA) Trial in Worldwide (Elsubrutinib, Upadacitinib, Placebo for elsubrutinib)

                Completed
                Has Results
                • Rheumatoid Arthritis (RA)
                • Huntsville, Alabama
                • +114 more
                Apr 6, 2021

                UCB Cimzia Pregnancy Follow-up Study

                Terminated
                • Rheumatoid Arthritis (RA)
                • +3 more
                  • Wilmington, North Carolina
                    Up0019 001
                  Apr 19, 2021

                  Rheumatoid Arthritis (RA), Spondyloarthritis (SA) Trial in Clermont-Ferrand (Argentine tango)

                  Completed
                  • Rheumatoid Arthritis (RA)
                  • Spondyloarthritis (SA)
                  • Argentine tango
                  • Clermont-Ferrand, France
                    CHU Clermont-Ferrand
                  Mar 4, 2021

                  Rheumatoid Arthritis (RA) Trial in Pittsburgh (TNF Antagonist (enbrel, humire, remicade, cimzia, symponi), Abatacept,

                  Terminated
                  Has Results
                  • Rheumatoid Arthritis (RA)
                  • TNF Antagonist (enbrel, humire, remicade, cimzia, symponi)
                  • +2 more
                  • Pittsburgh, Pennsylvania
                    University of Pittsburgh
                  Sep 9, 2020

                  Rheumatoid Arthritis (RA) Trial in Japan (ASP5094, Placebo, Methotrexate therapy)

                  Completed
                  • Rheumatoid Arthritis (RA)
                  • Asahikawa, Japan
                  • +30 more
                  Oct 31, 2019

                  Rheumatoid Arthritis (RA) Trial in Poland, United States (ASP5094, Placebo)

                  Completed
                  • Rheumatoid Arthritis (RA)
                  • Anniston, Alabama
                  • +12 more
                  Jun 26, 2019